Kinin B2 receptor can play a neuroprotective role in Alzheimer's disease

Neuropeptides

Volumn 53, Issue , 2015, Pages 51-62

  Caetano, A L ^a,d   Dong Creste, K E ^a,d   Amaral, F A ^a   Monteiro Silva, K C ^a   Pesquero, J B ^c   Araujo, M S ^c   Montor, W R ^a   Viel, T A ^b,d   Buck, H S ^a,d  

^a Medical Sciences School of Santa Casa of São Paulo   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d Research Group on Neuropharmacology of Aging   (Brazil)

Author keywords

Alzheimer's disease; Amyloid beta; B2 receptor; Bradykinin; Knockout mice

Indexed keywords

AMYLOID BETA PROTEIN; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; SYNAPTOPHYSIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; CELL BODY; CELL DENSITY; CONTROLLED STUDY; CORPUS CALLOSUM; DIAGONAL BAND OF BROCA; HIPPOCAMPUS; HYPOTHALAMUS POSTERIOR NUCLEUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PYRIFORM CORTEX; SUBSTANTIA INNOMINATA; SYNAPSE; THALAMUS NUCLEUS; AMYLOIDOSIS; ANIMAL; BRAIN CHEMISTRY; C57BL MOUSE; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; MEMORY; METABOLISM; NERVE CELL; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOIDOSIS; ANIMALS; BRAIN CHEMISTRY; HIPPOCAMPUS; MEMORY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; RECEPTOR, BRADYKININ B2; SYNAPSES;

EID: 84943821005     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2015.09.001     Document Type: Article

References (63)

1. Amaral F.A., Lemos M.T., Dong K.E., Bittencourt M.F., Caetano A.L., Pesquero J.B., Viel T.A., Buck H.S. Participation of kinin receptors on memory impairment after chronic infusion of human amyloid-β 1-40 (Aβ) peptide in mice. Neuropeptides 2010, 44:93-97.
2. Bascands J.L., Pecher C., Rouaud S., Emond C., Tack J.L., Bastie M.J., Burch R., Regoli D., Girolami J.P. Evidence for existence of two distinct bradykinin receptors on rat mesangial cells. Am J Physiol 1993, 264:F548-F556.
3. Bicca M.A., Costa R., Loch-Neckel G., Figueiredo C.P., Medeiros R., Calixto J.B. B[U+2082] receptor blockage prevents Aβ-induced cognitive impairment by neuroinflammation inhibition. Behav. Brain Res. 2015, 278:482-491.
4. Caetano A.L., Viel T.A., Bittencourt M.F., Araujo M.S., De Angelis K., Buck H.S. Change in central kinin B2 receptor density after exercise training in rats. Auton. Neurosci. 2010, 158(1-2):71-78.
5. Campos M.M., Ongali B., De Souza Buck H., Schanstra J.P., Girolami J.P., Chabot J.G., Couture R. Expression and distribution of kinin B1 receptor in the rat brain and alterations induced by diabetes in the model of streptozotocin. Synapse 2005, 57(1):29-37.
6. Cholewinski A.J., Stevens G., McDermott A.M., Wilkin G.P. Identification of B2 bradykinin binding sites on cultured cortical astrocytes. J. Neurochem. 1991, 57:1456-1458.
7. Cloutier F., de Sousa Buck H., Ongali B., Couture R. Pharmacologic and autoradiographic evidence for an up-regulation of kinin B(2) receptors in the spinal cord of spontaneously hypertensive rats. Br. J. Pharmacol. 2002, 135(7):1641-1654.
8. Cloutier F., Ongali B., Campos M.M., Thibault G., Neugebauer W., Couture R. Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats. Br. J. Pharmacol. 2004, 142:285-296.
9. Colom L.V., Castañeda M.T., Bañuelos C., Puras G., García-Hernández A., Hernandez S., Mounsey S., Benavidez J., Lehker C. Medial septal beta-amyloid 1-40 injections alter septo-hippocampal anatomy and function. Neurobiol. Aging 2010, 31(1):46-57.
10. Colom L.V., Castaneda M.T., Hernandez S., Perry G., Jaime S., Touhami A. Intrahippocampal amyloid-β (1-40) injections injure medial septal neurons in rats. Curr. Alzheimer Res. 2011, 8(8):832-840.
11. Couture R., Lindsey C.J. Brain kallikrein-kinin system: from receptors to neuronal pathways and physiological functions. Handbook of Chemical Neuroanatomy, Peptide Receptors 2000, 16:241-300. Elsevier Science B.V. R. Quirion, A. Björklund, T. Hökfelt (Eds.).
12. De Sousa Buck H., Ongali B., Thibault G., Lindsey C.J., Couture R. Autoradiographic detection of kinin receptors in the human medulla of control, hypertensive and diabetic donors. Can. J. Physiol. Pharmacol. 2002, 80(4):249-257.
13. Fior D.R., Martins D.T.O., Lindsey C.J. Localization of central pressor action of bradykinin in medulla oblongata. Am. J. Physiol. 1993, 265:H1000-H1006.
14. Fleisher-Berkovich S., Filipovich-Rimon T., Ben-Shmuel S., Hülsmann C., Kummer M.P., Heneka M.T. Distinct modulation of microglial amyloid β phagocytosis and migration by neuropeptides (i). J. Neuroinflammation 2010, 61:11-17.
15. Franklin K., Paxinos G. The Mouse Brain. In Stereotaxic Coordinates 2008, Academic Press, San Diego. third ed.
16. Fujiwara Y., Mantione C.R., Yamamura H.I. Identification of B2 bradykinin binding sites in guinea-pig brain. Eur. J. Pharmacol. 1988, 15(147(3)):487-488.
17. Hoffman W.E., Schimid P.G. Separation of pressor and antidiuretic effects of intraventricular bradykinin. Neuropharmacology 1978, 17:999-1002.
18. Huang H.M., Lin T.A., Sun G.Y., Gibson G.E. Increased inositol 1,4,5-trisphosphate accumulation correlates with an up-regulation of bradykinin receptors in Alzheimer's disease. J. Neurochem. 1995, 64(2):761-766.
19. Hunter W.M., Greenwood F.C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 1962, 194:495-496.
20. Iores-Marçal L.M., Viel T.A., Buck H.S., Nunes V.A., Gozzo A.J., Cruz-Silva I., Miranda A., Shimamoto K., Ura N., Araujo M.S. Bradykinin release and inactivation in brain of rats submitted to an experimental model of Alzheimer's disease. Peptides 2006, 27(12):3363-3369.
21. Jin K., Peel A.L., Mao X.O., Xie L., Cottrell B.A., Henshall D.C., Greenberg D.A. Increased hippocampal neurogenesis in Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(1):343-347.
22. Jong Y.J., Dalemar L.R., Seehra K., Baenziger N.L. Bradykinin receptor modulation in cellular models of aging and Alzheimer's disease. Int. Immunopharmacol. 2002, 2(13-14):1833-1840.
23. Kariya K., Yamauchi A. Effects of intraventricular injection of bradykinin on the EEG and the blood pressure in conscious rats. Neuropharmacology 1981, 20:1221-1224.
24. Kohno T., Wang H., Amaya F., Brenner G.J., Cheng J.K., Ji R.R., Woolf C.J. Bradykinin enhances AMPA and NMDA receptor activity in spinal cord dorsal horn neurons by activating multiple kinases to produce pain hypersensitivity. J. Neurosci. 2008, 28(17):4533-4540.
25. Kozlowski M.R., Rosser M.P., Hall E. Identification of 3H-bradykinin binding sites in PC-12 cells and brain. Neuropeptides 1998, 12:207-211.
26. Lacoste B., Tong X.K., Lahjouji K., Couture R., Hamel E. Cognitive and cerebrovascular improvements following kinin B1 receptor blockade in Alzheimer's disease mice. J. Neuroinflammation 2013, 4(10):57. 10.1186/1742-2094-10-57.
27. Leeb-Lundberg L.M.F., Marceau F., Müller-Esterl W., Pettibone D.J., Zuraw B.L. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 2005, 57:27-77.
28. Lemos M.T., Amaral F.A., Dong K.E., Bittencourt M.F., Caetano A.L., Pesquero J.B., Viel T.A., Buck H.S. Role of kinin B1 and B2 receptors on memory consolidation during aging process of mice. Neuropeptides 2010, 44:163-168.
29. Lindsey C.J., Buck H.S., Fior-Chadi D.R., Lapa R.C.R.S. Pressor effect mediated by bradykinin in the paratrigeminal nucleus of the rat. J. Physiol. 1997, 502(1):119-129.
30. 125I-Tyr8]-bradykinin receptor binding sites in the guinea pig spinal cord. Synapse 1983, 15:48-57.
31. López-Toledano M.A., Shelanski M.L. Increased neurogenesis in young transgenic mice overexpressing human APP(Sw, Ind). J. Alzheimers Dis. 2007, 12(3):229-240.
32. Ma J.X., Wang D.Z., Chao L., Chao J. Cloning, sequence analysis and expression of the gene encoding the mouse bradykinin B2 receptor. Gene 1994, 149:283-288.
33. Ma J.X., Wang D.Z., Ward D.C., Chen L., Dessai T., Chao J., Chao L. Structure and chromosomal localization of the gene (BDKRB2) encoding human bradykinin B2 receptor. Genomics 1994, 23:362-369.
34. Marceau F., Hess J.F., Bachvarov D.R. The B1 receptors for kinins. Pharmacol. Rev. 1998, 50(3):357-386.
35. Martins A.H., Alves J.M., Perez D., Carrasco M., Torres-Rivera W., Eterović V.A., Ferchmin P.A., Ulrich H. Kinin-B2 receptor mediated neuroprotection after NMDA excitotoxicity is reversed in the presence of kinin-B1 receptor agonists. PLoS One 2012, 7(2):e30755. 10.1371/journal.pone.0030755.
36. Martins A.H., Alves J.M., Trujillo C.A., Schwindt T.T., Barnabé G.F., Motta F.L., Guimaraes A.O., Casarini D.E., Mello L.E., Pesquero J.B., Ulrich H. Kinin-B2 receptor expression and activity during differentiation of embryonic rat neurospheres. Cytometry A 2008, 73(4):361-368. 10.1002/cyto.a.20519.
37. Mathis S.A., Criscimagna N.L., Leeb-Lundberg L.M.F. B1 and B2 kinin receptors mediate distinct patterns of intracellular Ca2+ signaling in single cultured vascular smooth muscle cells. Mol. Pharmacol. 1996, 50:128-139.
38. Mulder M., Jansen P.J., Janssen B.J., van de Berg W.D., van der Boom H., Havekes L.M., de Kloet R.E., Ramaekers F.C., Blokland A. Low-density lipoprotein receptor knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampus. Neurobiol. Dis. 2004, 16:212-219.
39. Murone C., Paxinos G., McKinley M.J., Oldfield B.J., Muller-Esterl W., Mendelsohn F.A., Chai S.Y. Distribution of bradykinin B2 receptors in sheep brain and spinal cord visualized by in vitro autoradiography. J. Comp. Neurol. 1997, 381:203-218.
40. 125I-brain paste standards for use in quantitative receptor autoradiography. J. Neurosci. Methods 1989, 30(3):247-253.
41. Noda M., Kariura Y., Pannasch U. Neuroprotective role of bradykinin because of the attenuation of pro-inflammatory cytokine release from activated microglia. J. Neurochem. 2007, 101:397-410.
42. Okada Y., Tuchiya Y., Yagyu M., Kozawa S., Kariya K. Synthesis of bradykinin fragments and their effect on pentobarbital sleeping time in mouse. Neuropharmacology 1977, 16:381-383.
43. Ongali B., Buck H de S., Cloutier F., Legault F., Regoli D., Lambert C., Thibault G., Couture R. Chronic effects of angiotensin-converting enzyme inhibition on kinin receptor binding sites in the rat spinal cord. Am. J. Physiol. Heart Circ. Physiol. 2003, 284(6):H1949-H1958.
44. Ongali B., Campos M.M., Bregola G., Rodi D., Regoli D., Thibault G., Simonato M., Couture R. Autoradiographic analysis of rat brain kinin B1 and B2 receptors: normal distribution and alterations induced by epilepsy. J. Comp. Neurol. 2003, 461(4):506-519.
45. Ongali B., Hellal F., Rodi D., Plotkine M., Marchand-Verrecchia C., Pruneau D., Couture R. Autoradiographic analysis of mouse brain kinin B1 and B2 receptors after closed head trauma and ability of anatibant mesylate to cross the blood-brain barrier. J. Neurotrauma 2006, 23(5):696-707.
46. Pillat M.M., Cheffer A., de Andrade C.M., Morsch V.M., Schetinger M.R., Ulrich H. Bradykinin-induced inhibition of proliferation rate during neurosphere differentiation: consequence or cause of neuronal enrichment?. Cytometry A 2015, 10.1002/cyto.a.22705.
47. Prado G.N., Taylor L., Zhou X., Ricupero D., Mierke D.F., Polgar P. Mechanisms regulating the expression, self-maintenance, and signaling-function of the bradykinin B2 and B1 receptors. J. Cell. Physiol. 2002, 193:275-286.
48. Prat A., Biernacki K., Pouly S., Nalbantoglu J., Couture R., Antel J. Kinin B1 receptor expression and function on human brain endothelial cells. J. Neuropathol. Exp. Neurol. 2000, 59:896-906.
49. Prat A., Weinrib L., Becher B., Poirier J., Duquette P., Couture R., Antel J.P. Bradykinin B1 receptor expression and function on T lymphocytes in active multiple sclerosis. Neurology 1999, 53:2087-2092.
50. Prediger R.D., Medeiros R., Pandolfo P., Duarte F.S., Passos G.F., Pesquero J.B., Campos M.M., Calixto J.B., Takahashi R.N. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease. Neuroscience 2008, 151(3):631-643.
51. Raidoo D.M., Ramchurren N., Naidoo Y., Naidoo S., Müller-Esterl W., Bhoola K.D. Visualisation of bradykinin B2 receptors on human brain neurons. Immunopharmacology 1996, 33:104-107.
52. Regoli D., Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 1980, 32:1-46.
53. Regoli D., Nsa Allogho S., Rizzi A., Gobeil F.J. Bradykinin receptors and their antagonists. Eur. J. Pharmacol. 1998, 348(1):1-10.
54. Sharif N.A., Whiting R.L. Identification of B2-bradykinin receptors in guinea pig brain regions, spinal cord and peripheral tissues. Neurochem. Int. 1991, 18:89-96.
55. Smith J.A.M., Davis C.L., Burgess G.M. Prostaglandin E2-induced sensitization of bradykinin-evoked responses in rat dorsal root ganglion neurons is mediated by cAMP-dependent protein kinase A. Eur. J. Neurosci. 2000, 12:3250-3258.
56. Smith J.A.M., Webb C., Holford J., Burgess G.M. Signal transduction pathways for B1 and B2 bradykinin receptors in bovine pulmonary artery endothelial cells. Mol. Pharmacol. 1995, 47:525-534.
57. Tarsa L., Goda Y. Synaptophysin regulates activity dependent synapse formation in cultured hippocampal neurons. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:1012-1016.
58. Thornton E., Ziebell J.M., Leonard A.V., Vink R. Kinin receptor antagonists as potential neuroprotective agents in central nervous system injury. Molecules 2010, 15(9):6598-6618.
59. Viel T.A., Buck H.S. Kallikrein-kinin system mediated inflammation in Alzheimer's disease in vivo. Curr. Alzheimer Res. 2011, 8(1):59-66.
60. Viel T.A., Lima Caetano A., Nasello A.G., Lancelotti C.L., Nunes V.A., Araujo M.S., Buck H.S. Increases of kinin B1 and B2 receptors binding sites after brain infusion of amyloid-beta 1-40 peptide in rats. Neurobiol. Aging 2008, 29(12):1805-1814.
61. Wang Q., Wang J. Injection of bradykinin or cyclosporine A to hippocampus induces Alzheimer-like phosphorylation of Tau and abnormal behavior in rats. Chin. Med. J. 2002, 115(6):884-887.
62. Yu Y., He J., Zhang Y., Luo H., Zhu S., Yang Y., Zhao T., Wu J., Huang Y., Kong J., Tan Q., Li X.M. Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model. Hippocampus 2009, 12:1247-1253.
63. Zhao W.Q., Ravindranath L., Mohamed A.S., Zohar O., Chen G.H., Lyketsos C.G., Etcheberrigaray R., Alkon D.L. MAPkinase signaling cascade dysfunction specific to Alzheimer's disease in fibroblast. Neurobiol. Dis. 2002, 11(1):166-183.